Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil Hydroworld Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Acadia Pharmaceutica (NQ: ACAD ) 17.05 UNCHANGED Streaming Delayed Price Updated: 4:00 PM EDT, May 3, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings All News about Acadia Pharmaceutica < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > 10 Health Care Stocks Whale Activity In Today's Session November 02, 2023 Via Benzinga Acadia Pharmaceuticals to Participate in the Guggenheim Securities 5th Annual Inflammation & Immunology Conference October 31, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Announces the Rett Sibling Scholarship Program October 23, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Announce Third Quarter Financial Results on November 2, 2023 October 19, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Analyst Ratings for ACADIA Pharmaceuticals October 10, 2023 Via Benzinga Why Acadia Pharmaceuticals Stock Is Rising Today October 10, 2023 An analyst upgrade is sparking a rally in the drugmaker's shares today. Via The Motley Fool 2 Growth Stocks I'd Buy on the Dip September 30, 2023 These two growth stocks could be worthwhile buy-and-holds. Via The Motley Fool Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) October 18, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Benzinga's Top Ratings Upgrades, Downgrades For October 17, 2023 October 17, 2023 Via Benzinga Analyst Ratings for ACADIA Pharmaceuticals August 22, 2023 Via Benzinga Benzinga's Top Ratings Upgrades, Downgrades For October 10, 2023 October 10, 2023 Via Benzinga Electronic Arts To Rally Over 20%? Here Are 10 Other Analyst Forecasts For Tuesday October 10, 2023 JP Morgan increased ACADIA Pharmaceuticals Inc. (NASDAQ: ACAD) price target from $29 to $32. JP Morgan analyst Tessa Romero upgraded the stock from Neutral to Overweight. ACADIA Pharmaceuticals shares... Via Benzinga 10 Health Care Stocks Whale Activity In Today's Session October 02, 2023 Via Benzinga Can This Red-Hot Biotech Stock Keep Beating the Broader Markets? August 22, 2023 This biotech stock has been on fire in 2023. Via The Motley Fool Analyst Expectations for ACADIA Pharmaceuticals's Future August 03, 2023 Via Benzinga 12 Health Care Stocks Moving In Thursday's Intraday Session September 28, 2023 Via Benzinga Why CarMax Shares Are Trading Lower By Around 10%? Here Are Other Stocks Moving In Thursday's Mid-Day Session September 28, 2023 Gainers Bionomics Limited (NASDAQ: BNOX) shares jumped 308% to $4.00 after the company announced the ATTUNE trial met its primary endpoint showing BNC210 treatment led to a statistically significant... Via Benzinga ACADIA Pharmaceuticals's Earnings: A Preview August 01, 2023 Via Benzinga Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) September 22, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Appoints Albert Kildani as Senior Vice President, Investor Relations and Corporate Communications September 19, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Participate at Upcoming Investor Conferences August 30, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire 2 Supercharged Growth Stocks Billionaires Can't Stop Buying August 28, 2023 A top hedge fund has been steadily buying these two growth stocks in 2023. Via The Motley Fool This Under-the-Radar Growth Stock Could Soar by 277%, According to Wall Street August 16, 2023 This small-cap biotech might be a hidden gem. Via The Motley Fool Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 14, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire JP Morgan Maintains Neutral Rating for ACADIA Pharmaceuticals: Here's What You Need To Know August 07, 2023 Via Benzinga Acadia Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operating Overview August 02, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) August 01, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals Appoints Kevin R. Oliver, Ph.D., as Senior Vice President, Chief Business Officer July 24, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals to Announce Second Quarter Financial Results on August 2, 2023 July 19, 2023 From Acadia Pharmaceuticals Inc. Via Business Wire Acadia Pharmaceuticals: A Mid-Cap Biotech Making Large Moves July 18, 2023 Acadia may experience a profit-taking pullback near-term but the recent high volume gapper and promising pipeline developments bode well for long-term uptrend. Via MarketBeat < Previous 1 2 3 4 5 6 7 8 9 ... 12 13 Next > Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.